You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.

MONTVALE, N.J. and TOKYO, April 7, 2020 /PRNewswire/ -- HOYA Corporation and a subsidiary through PENTAX Medical division, Pentax of America, Inc. (collectively, "PENTAX" or "the Company"), today finalized a Deferred Prosecution Agreement (DPA) with the U.S. Department of Justice (DOJ) on issues related to the timely filing of Medical Device Reports (MDRs) for PENTAX Medical's duodenoscopes and providing updated Instructions for Use (IFUs) for several PENTAX Medical products. PENTAX first disclosed the DOJ investigation in June 2015. In the DPA, PENTAX acknowledged that it did not timely submit two required MDRs to the U.S. Food and Drug Administration (FDA) for events in the US between July 2013 and December 2014. In addition, PENTAX acknowledged that it failed to send FDA approved IFUs for four types of endoscopes from April 2014 until September 2015. PENTAX agreed to: pay a fine and forfeiture totaling $43 million; undertake new steps to enhance its compliance policies and procedures; and regularly make certain certifications that PENTAX is meeting the requirements of the DPA. "PENTAX deeply regrets that it did not timely file the MDRs identified in the DPA, as well as the failure to send the approved IFUs to customers. We accept full responsibility for these failures," said David Woods, President of Pentax of America, Inc. The DPA does not allegeany direct harm to patients as a result of the disclosure failures or failure to send IFUs, and PENTAX acknowledged that it failed to comply with the federal reporting requirements. The DPA does not impact the availability of PENTAX Medical products and services worldwide. "PENTAX Medical is committed to the highest standards of ethical behavior and we are confident we can fulfill each of the obligations under this DPA to the fullest extent necessary," said Gerry Bottero, Global President, PENTAX Medical. The full text of the DPA will be available on the PENTAX Medical website. At PENTAX Medical, we have an unwavering commitment to our customers and their patients to provide safe, high-quality products and services that offer true value. To that end, we develop products and services that enable our customers to improve clinical outcomes, reduce the cost of healthcare, and enhance the experience they deliver to patients. This approach is demonstrated in how we develop clinically relevant endoscopy products, advance cleaning procedures, continuously improve our internal procedures, and empower our customers through expert training and education programs. While we always strive to deliver on our promises, how we achieve those results is equally as important. About PENTAX MedicalPENTAX Medical is a division of HOYA Group. The company's mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY.Through providing endoscopic imaging devices and solutions to the global medical community and with its headquartered in Japan, PENTAX Medical has a worldwide focus and a strong presence with R&D, regional sales, service, and in-country facilities in multiple regions around the globe.PENTAX Medical'sTriple Aim programstrives to deliver on the commitment to support its customers and their healthcare organization's wider objectives through a transparent partnership and by providing the highest quality solutions to help them reach their goals. Enabling customers to improve patient outcomes by offering evidenced based solutions across the continuum of care, dedicated to their needs. From screening through to therapy with full scalabilities. Ensuring values by supporting the customers to improve their efficiency and minimize their healthcare costs. Enriching patient and provider's experience by empowering every member of the care team to achieve optimal outcomes through products, education and support. For more information, please visit: www.pentaxmedical.com. For more information, please visithttps://www.pentaxmedical.com. About HOYAFounded in 1941 in Tokyo, Japan, HOYA Corporation is a global technology and med-tech company and a leading supplier of innovative high-tech and medical products. HOYA's divisions and business units research and develop products utilized in the healthcare and information technology fields.In the healthcare field, we provide medical device products such as eyeglasses, medical endoscopes, contact and intraocular lenses, orthopedic implants, surgical/therapeutic devices and medical device reprocessing and disinfection solutions. In the information technology field, we provide products such as optical lenses, photomasks and blanks used in the manufacturing process for semiconductor and LCD/OLED devices, text to speech, human resources and other software solutions and critical components for the mass memory and cloud storage industries. With over 150 offices and subsidiaries worldwide, HOYA currently employs a multinational workforce of 37,000 people. For more information, please visithttp://www.hoya.com Mariano Franco 1 (905) 580-7725 [emailprotected] SOURCE PENTAX Medical Related Links https://www.pentaxmedical.com

Answer: HOYA/PENTAX Medical Issues Statement Regarding U.S. Department of Justice Settlement English Latin America - espaol English Franais Deutsch